Skip to main content

Collaborative model of care between Orthopaedics and allied healthcare professionals in knee osteoarthritis (CONNACT): study protocol for an effectiveness-implementation hybrid randomized control trial



Knee Osteoarthritis (OA) is a leading cause of global disability. The Collaborative Model of Care between Orthopaedics and Allied Healthcare Professionals (CONNACT) Model of Care (MoC) was developed by optimizing evidence-based non-surgical treatments to deliver value-based care for people with knee OA. The primary aim of this study is to determine the clinical effectiveness of the CONNACT MoC (3 months) compared to usual care. The secondary aims are: a) To determine the cost-effectiveness and b) To develop an evaluation and implementation framework to inform large scale implementation for this MoC.


Type 1 Effectiveness-Implementation Hybrid Trial using an explanatory sequential mixed-method approach. The study consists of 3 components. The first component is the pragmatic, parallel-arm, single-blinded randomized control trial. Inclusion criteria are patients with knee OA based on the National Institute of Health and Care Excellence (NICE) criteria with radiographic severity of greater than Kellgren-Lawrence 1, and Knee Injury and OA Outcome Score (KOOS4) of equal or less than 75. Exclusion criteria include other forms of arthritis, history of previous knee arthroplasty or wheelchair-bound patient. KOOS4 is the primary outcome measure at 3 months, 6 months and 1 year. Secondary outcomes include KOOS individual subscales, quality of life scoring, functional performance, global, diet and psychological related outcomes. The second component is an economic evaluation of the cost-effectiveness of the CONNACT MoC using a societal perspective. The third component is an implementation and evaluation framework using process evaluation under the RE-AIM framework using a mixed-method approach. Sample size of 100 patients has been calculated.


CONNACT MoC is a complex intervention. In line with the MRC guidance for developing and evaluating complex interventions, a pilot feasibility study was completed and a comprehensive approach including an RCT, economic evaluation and process evaluation is described in this study protocol. Results from this study will help clinicians, healthcare administrators and policymakers guide the sustainable and effective implementation of the CONNACT MoC for knee OA and serve as a basis for similar multidisciplinary MoC for chronic degenerative musculoskeletal conditions to be developed.

Trial registration Identifier: NCT03809975. Registered January 182,019.

Peer Review reports


The world is experiencing a rapidly aging population, and with it an age-related increase in chronic musculoskeletal (MSK) disorders. Based on the 2010 Global Burden of Disease Study, MSK disorders account for the largest cause of disability around the world and in particular, osteoarthritis (OA) was ranked the 11th highest global cause [1]. International guidelines are consistent in their treatment recommendations for knee OA with individualized lifestyle changes, especially exercise and weight loss programs, highlighted as first-line management [2, 3]. A stepwise approach is recommended where surgery is considered when non-surgical treatment fails. Despite all this, studies report that more than half of the patients from established healthcare systems around the world such as Australia and Canada are not receiving optimal non-surgical treatment [4,5,6].

Surgery is often a result not from a failure of non-surgical treatment but the failure of the healthcare system to provide adequate and effective non-surgical treatment. With knee arthroplasty rates expected to rise rapidly [7], the literature suggests that at least a quarter of knee arthroplasties could have been avoided through optimal non-surgical treatments [8]. While knee arthroplasty surgery is an effective option for knee OA, it should be applied only when all non-surgical treatment options have been exhausted as it is costly and not without risks and complications [9].

There is an urgent need for new models of care (MoC) for knee OA developed by optimizing evidence-based non-surgical treatments to deliver value-based care. There has been a paradigm shift globally, moving from an acute episodic type treatment that was generally associated with OA to a chronic disease MoC [10]. Over the past decade, several models of care from around the world have been developed including the Good Life with OA in Denmark (GLA:D) program and the OA Chronic Care Program (OACCP) program from Australia [11]. Building from the well-established principles of these programs, the Collaborative Model of Care between Orthopaedics and Allied Healthcare Professionals (CONNACT) Model of Care (MoC) of knee OA was developed. CONNACT is a community-based, multidisciplinary 12-week program that uniquely uses an individualized approach based on a triaging criterion to tailor the treatment to each patient in line with the “right care, delivered at the right time, by the right team, in the right place, with the right resources” philosophy coupled with a strong emphasis on patient activation and self-management strategies to promote long term sustainable behavioural change.

The Medical Research Council (MRC) Guidance on developing and evaluation such complex interventions was utilized in the CONNACT development, evaluation and eventual planned implementation [12]. A feasibility study using a pilot randomized trial design was conducted to determine the feasibility of a full randomized controlled trial (RCT) evaluating the CONNACT MoC as the first step [13]. Results from the feasibility study were instrumental in the design of this study protocol.


The primary aim of the study is to evaluate the clinical effectiveness (pain, function, quality of life) of the CONNACT MoC as compared with usual care in patients with knee OA.

The secondary aims are to:

  1. 1.

    Evaluate the cost-effectiveness of the CONNACT MoC for patients with knee OA

  2. 2.

    Develop an implementation and evaluation framework to inform large scale implementation of CONNACT MoC

We hypothesize that patients with knee OA who undergo the CONNACT program will have better pain, function and quality of life scores 12 months after initiating the program compared to patients who undergo usual care.



The study is an Effectiveness-Implementation Hybrid Trial which combines both an effectiveness and implementation component [14, 15]. It has been increasingly recognized that implementation is the main challenge in many models of care. An implementation gap, also known as the “valley of death” exists between what current literature recommendation and translation to actual clinical practice [16]. Knee OA is a clear situation where this “valley of death” has happened. As a result, there has been a greater emphasis on incorporation of an implementation element in studies to enhance dissemination with hybrid trials increasingly being conducted [17].

This will be a type 1 hybrid trial where the emphasis and primary aim is to evaluate effectiveness through a pragmatic randomized trial under real-world conditions and its secondary aim is to understand the context of implementation through a mixed-method, process orientated approach. The pragmatic nature of the study was guided by the Pragmatic Explanatory Continuum Indicator Summary (PRECIS-2) tool [18].

The study will be conducted as a single centre pragmatic, parallel-arm, single-blinded RCT using a mixed-method approach comparing the CONNACT multidisciplinary personalized community-based MoC and the current MoC. The Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) [19] model (Additional file 5) and the OA Research Society International (OARSI) clinical trial recommendation on the design and conduct of clinical trials for knee OA [20] guided the development and reporting of the trial protocol. The findings of the trial will be reported according to the Consolidated Standards of Reporting Trials (CONSORT) 2010 [21] guidelines for reporting parallel group randomized trials. The study will utilize an explanatory sequential mixed methods design where the qualitative data through the use of surveys and interviews will be used to interpret and provide context for the quantitative results.

Ethics approval

Ethics approval has been obtained from the Institution Review Board (IRB) prior to the conduct of the study (NHG DSRB Ref: 2018/00408). Any protocol modification will be communicated to IRB in a timely manner. Random audits will be performed by the IRB.


We will recruit patients based on the inclusion and exclusion criteria outlined in Table 1.

Table 1 Inclusion and Exclusion Criteria

Components of the CONNACT study

  1. 1.

    Randomized Controlled Trial

  2. 2.

    Economic evaluation

  3. 3.

    Implementation and Evaluation Framework

COMPONENT 1: randomized controlled trial

Trial procedure

The overall flow for the RCT is outlined in Fig. 1 based on the CONSORT guidelines. Patients who are referred by a primary healthcare or emergency medicine doctor to the Outpatient clinic at the Department of Orthopaedic Surgery at Tan Tock Seng Hospital, a tertiary referral centre in Singapore with a suspected diagnosis of knee OA will be screened based on the inclusion and exclusion criteria presented in Table 1. All referral letters are screened based on electronic medical records.

Fig. 1

Randomized Control Trial Structure

Patients who are eligible based on initial screening are invited to attend a recruitment clinic where they will be assessed by the study team and invited to participate in the study if they meet all the inclusion and exclusion criteria. Informed written consent will be obtained. Patients will be randomized into the intervention or usual care arm after collection of baseline data. Recruitment clinics will be carried out at the Tan Tock Seng Hospital Specialist Outpatient Clinic.

Randomization and concealment of allocation

Patients who consent to participate will be randomized (1:1 allocation ratio) between the intervention and usual care using a stratified permuted block randomization method using block sizes of 4,6 and 8. Stratification is based on gender to ensure equal distribution in both groups. The allocation sequence is generated by an independent statistician a priori and will be kept concealed from the study team. Randomization will be done using the REDCap randomization module based on the allocation sequence and allocation will be locked once assigned. Randomization and intervention allocation will only be performed by the study team after the patient is counselled fully about the study and provides informed consent.

Intervention – CONNACT model of care

The development and core principles of the CONNACT MoC has been described as part of the pilot study [25]. Grounded from a throughout literature search on the best practices in knee OA care [3, 26], a review of successful programs [11], international collaborations and the process evaluation patient interviews from the pilot study has allowed the CONNACT MoC to be further refined and contextualized.

The CONNACT MoC consists of a 12-week community based, individualized, multidisciplinary intervention for knee OA. In summary, the core principles are firstly a chronic disease multidisciplinary model emphasizing self-management and long term sustainable behavioural change, secondly, care stratification using a triage criterion and thirdly, implemented through a grounded community-based setting.

Table 2 outlines the intervention summary, including each component, triaging criterion, intervention principles and delivery. A full description of the intervention in accordance with TIDieR [27] and CERT [28] reporting guidelines is available in the Additional file 1. Further rationale and details for the triaging criterion and the self-management philosophy underpinning the CONNACT MoC are elaborated below.

Table 2 Intervention Summary

Triaging criteria development

The 3 measures that were chosen for psychological intervention triaging criteria were Patient Health Questionnaire-4 (PHQ-4) [35], and Pain Intensity, Enjoyment of life and General Activity (PEG) [36] and Patient Activated Measure (PAM) [37].

PHQ-4 and PEG were chosen in light of the significant impact of psychological conditions (anxiety, depression) and pain intensity and interference in predicting outcomes in OA patients [38, 39]. The Pain Intensity, Enjoyment of life and General Activity (PEG) [36] is a brief, 3-item assessment of pain intensity (1item) and pain interference (2 items) derived from the Brief Pain Inventory (BPI) [40]. The PEG measures pain intensity on a numerical rating scale of ‘0’ (no pain) to ‘10’ (pain as bad as you can imagine) and pain interference with general activity and enjoyment of life also on a ‘0’ (does not interfere) to ‘10’ (completely interferes) scale. Provisional benchmarks have been set to identify clinically meaningful improvements that can help differentiate between treatment “responders” and “non-responders” at the start of a clinical trial [41] Suggestions that symptom reduction of 30% or more indicating moderately important improvements and symptom reduction of 50% or more considered “substantial improvements”. Taking reference from these guidelines, a cut-off score of “5” indicating moderate symptoms for pain, physical functioning was used to decide for psychological intervention.

The Patient Health Questionnaire-4 (PHQ-4) [35] is a brief 4-item screening assessment of depression and anxiety symptoms. With anxiety known to exert an independent effect on functioning separate from depression, screening for both depression and anxiety has been thought to be necessary [42]. The first 2 items from the PHQ-4 are taken from the original 9 item Patient Health Questionnaire (PHQ-9) and the next 2 items taken from the first 2-items on the General Anxiety Disorder (GAD-7) questionnaire. The PHQ-4, therefore, forming a composite score of depression and anxiety. Responses on all 4 items are scored as “0” (not at all), “1” (several day”, “2″ (more than half the days) and “3″ (nearly every day). A score of more than 5 indicates at least a moderate psychological distress from depression and/or anxiety and thus was used as cut off for psychological intervention.

Patient activation is defined as an individual’s propensity to engage in adaptive health behaviour that may lead to improved outcomes. Activation levels are measured by the Patient Activated Measure (PAM) [37], a validated questionnaire that looks at knowledge, skills and confidence in managing health. Through the PAM score, patients can subsequently put into 4 groups, level 1 (poorly activated) to level 4 (highly activated). There has been increasing evidence in the literature that PAM scores are modifiable through targeted intervention and that high PAM scores have been associated with more satisfaction with healthcare services, better self-management behaviour and improved health outcome [43, 44]. As such, PAM levels of 1 and 2 were chosen as a triaging criterion for targeted psychological intervention in an effort to boost activation levels.

Body Mass Index will be used as a triaging criterion for dietetic intervention. A lower cut off of BMI 23.5 has been recommended for Asians [45] and will be used as a cut-off.

Self-management philosophy

Self-management is a key foundation for the CONNACT MoC. This will be achieved through several methods. Firstly, through the program content. The education and psychology classes grounded in the principles and psychological model of Acceptance and Commitment Therapy (ACT) [32, 33] and Patient Activation [34] strategies which have been shown to the effective. In particular, there has already been evidence to show the effectiveness of ACT in the local chronic pain population in Singapore [46].

Secondly, through the program delivery format. The program’s duration of 12 weeks is based on current evidence of the time taken for a habit to form [47]. The program is structured as a weekly class with a gap of 3 weeks between week 8 and week 12 factored in to allow patients the opportunity to incorporate these behavioural modifications as part of their daily routine before returning for the final session on week 12. In addition, after each session, patients will be given “homework” and exercises to perform at home and are reviewed at the next class. This combination of class-based and home-based individual treatment has been shown to be effective in knee OA [48]. In addition, group or class-based interventions have also been shown to be more effective compared to pure individual interventions in promoting physical activity through cohesion and peer support [49]. A flexible post-intervention program will be available for patients who would like to continue to exercise together in a group and social network platforms e.g. Whatsapp group chats or Facebook groups will also be utilized to facilitate patient group interaction throughout and post-intervention. In addition, a support group session 3 months after program completion will be arranged for reinforcement for key concepts and continued promotion of group interaction.

Thirdly, through the use of “expert patients”. These “expert patients” are patients who have previously completed and benefitted from the CONNACT program. They will be invited to volunteer and share their experiences and advice as part of the education class to serve as a role model for patients. “Expert patients” been successfully incorporated in other knee OA programs before [30].

Usual care

Usual care constitutes a referral to the outpatient physiotherapist at the tertiary hospital where patients are usually seen 1–2 weeks post referral. The physiotherapist would conduct an assessment and recommend a variety of lifestyle modifications and exercise therapy. The type of exercises and number of physiotherapy sessions were at the discretion of the patient and the physiotherapist.

Outcome assessment and blinding

Outcome measures will be measured by blinded outcome assessors. The outcome assessors will be either physiotherapy interns or research assistants. All outcome assessors will receive training prior to study initiation to ensure good inter- and intra-observer reliability, particularly for the functional performance testing. Patients will be instructed not to reveal their allocation to the outcome assessors. Outcome assessment will be conducted either at the community rehabilitation facility or tertiary hospital setting. Choice of outcome assessment location will be carefully monitored to ensure that outcomes assessors were not able to deduce the treatment arm.


The choice of outcome measures is based on the OARSI guidelines for lifestyle diet and exercise clinical trials in OA [50]. The recommended core outcomes are pain, physical function, global patient assessment and mobility. Additional outcomes include health-related quality of life and global physician assessment. The outcome measures will be collected at baseline, 3, 6 and 12 months. Table 3 summarizes all the outcome measures and Additional file 4 outlines the different data collection steps based on the SPIRIT guidelines.

Table 3 Outcome Measures Overview

Baseline measures

The following baseline measures will be collected.

  1. 1.

    Demographic – age, gender, race

  2. 2.

    Socioeconomic status – education level, housing status, employment details

  3. 3.

    Co-morbidities and functional status – Charlson comorbidity index [58], Barthel Index for Activities of Daily Living [59], Parker Mobility Score [60]

  4. 4.

    Knee symptoms and duration

  5. 5.

    Radiographic severity of knee OA based on the Kellgren Lawrence Scale [23]

Primary outcome

The primary outcome measure will be the mean of four of the five subscale scores from the Knee Injury and OA Outcome Score (KOOS4). KOOS contains 5 domains of questions, namely symptoms, pain, function (daily living), function (sports, recreational activities) and quality of life [24]. Consistent with other studies with a similar population of elderly patients with knee OA, the function (sports, recreational activities) subscale were deemed to be less relevant for this population and the remaining 4 domains were combined to form a composite score [61]. The KOOS score has previously been validated in Singapore [62].

Secondary outcomes

The secondary outcomes have been classified into effectiveness and compliance outcomes. The effectiveness measures have been further subdivided based which aspect of the treatment it is likely to have the greatest impact on.

Physical function outcomes

Secondary physical function outcome outcomes included KOOS individual subscales, functional performance and ULCA activity score. The choice of functional performance tests was based on the recommended OARSI performance test for functional testing in OA [63]. A 4 × 10 m fast-paced walk test, timed up-and-go, 4-stair climb test and 30-s chair stand were chosen to encompass the key domains of functional activities from sit-to-stand, walking short distances, stair negotiation and ambulatory transitions. The ULCA activity score is a validated score that is recommended for use in patients with hip or knee OA [64].

Dietetics outcomes

In addition to Body Mass Index, Food Frequency Questionnaire (FFQ) will be collected to monitor for change in dietary habits. Modification to the original Food Frequency Questionnaire (FFQ) was performed to reduce the length and thereby responder burden and adapt it based on local dietary practices. Scoring was developed by weighting fat/sugar/fibre content of the particular food item based on the energy and nutrient composition reported by the Singapore Health Promotion Board ( Modified FFQ will only be done for patients who have a BMI > 23.5.

Psychological outcomes

The Pain Interference Scale (Pain intensity (P), interference with enjoyment of life (E), interference with general activity (G))(PEG) [36] is a 3 item scale developed and validated from the Brief Pain Inventory(BPI) for chronic pain measurement, particularly in chronic musculoskeletal patients. The Patient Health Questionnaire-4 (PHQ-4) [35] is a validated questionnaire that allows measurement of both anxiety and depression, both common psychological conditions associated with poorer quality of life in OA patients [38]. Patient activation is defined as an individual’s propensity to engage in adaptive health behaviour that may lead to improved outcomes [43, 44]. Activation levels are measured by the Patient Activated Measure (PAM) [37], a validated questionnaire that looks at knowledge, skills and confidence in managing health.

General outcomes

Quality of Life will be measured using the EQ-5D, both the descriptive index and EQ-VAS [51]. The EQ-5D value set that has been validated for the Singapore population using a time trade-off method and was used to calculate utility values [65]. It will also be used in the computation for Quality of Life Years (QALYs) and eventual cost-effectiveness.

Analgesia consumption will be measured using the Cumulative Analgesia Consumption Scale (CACS) which measures both the quantity and potency of the analgesia based on WHO analgesia ladder over a 1 week period [57].

Global perceived effect (GPE) [53] will be assessed with the question: With respect to your knee, how would you describe yourself now compared to before the treatment?? Answered on a seven-point Likert scale ranging from ‘Improved, an important improvement’ to ‘Worse, an important worsening’. Satisfaction with current knee function will be assessed by the Patient Acceptable Symptom State (PASS) [54] using the question: “When you think of your knee function, will you consider your current condition as satisfying? Answered by ‘yes’ or ‘no’. Participants not satisfied with current knee function will be asked to complete a second single-item question, relating to treatment failure (TF) at the 12-month follow-up: ‘Would you consider your current state as being so unsatisfactory that you think the treatment has failed?’. Answered by ‘yes’ or ‘no’.

Any adverse events (AE) and serious adverse events (SAE) will be collected during all follow-up visits using open-probe questioning to ensure all AE are recorded. SAE will be defined as any AE that results in hospitalization or is life-threatening. Participation in the trial for the subject will cease if a SAE occurs. Undergoing an indicated surgical procedure such as a knee arthroplasty for knee OA due to failure of non-surgical treatment will not be considered an AE. In the event of more than 3 SAE, decision to stop the trial will be considered however the final decision will be made by the Principal Investigator (PI) in conjunction with the ethics and clinical board. Provision for post-trial care and compensation will be made for subjects who suffer harm during the course of the trial.

Compliance and adherence

Compliance and adherence are key aspects in any exercises-based intervention for MSK conditions and having compliance measures allows for a more accurate interpretation of the results and form a significant part of the process evaluation [66]. Unfortunately, there is no specific measure for exercise adherence that has been proven to be high quality, relevant and acceptable [67]. In order to give a holistic picture to adherence, the Sports Injury Rehabilitation Adherence Scale (SIRAS) [55] will provide the healthcare providers perspective while a self-administered questionnaire for patients has been designed to obtain patient’s input (Additional file 2). SIRAS is a 3-item instrument that assesses patient’s intensity to exercise, the extent to which instructions were followed and receptiveness to change during each rehabilitation session. SIRAS will be done after each physiotherapy session and the exercise adherence questionnaire will be done at 3, 6 and 12 months. These adherence measures will only be performed in the intervention arm patients due to the variability of treatment delivery in the usual care arm. Non-compliance will be defined as less than 75% attendance of the prescribed treatment in the intervention arm. For usual care, the number of physiotherapy sessions will be at the discretion of the patient; thus, no non-compliance cut off limit will be set.

Sample size calculation

The sample size needed to detect a 10-point difference between the intervention arm and usual care arm in KOOS4 was 41 patients in each arm based on a power of 90%, p-value of 0.05 (two-sided) and a standard deviation of 14. The anticipated population KOOS4 and standard deviations were based on the initial pilot study [25] done and the minimally clinically important difference on 10-points (MCID) for KOOS [24]. In order to account for a missing data rate of 20%, 100 patients will be recruited for the study.

Analysis plan

The primary endpoint in this study is KOOS4 at 12-month follow-up. Results will be analysed by intention-to-treat (ITT) principle. However, data will also be analysed by per-protocol (PP) approach to account for protocol violations such as patients who were deemed not compliant to treatment or patients who underwent a surgical procedure of the knee due to treatment failure during the course of the study.

Descriptive frequency analysis will be used for baseline characteristics. For continuous variables, the mean and standard deviation will be reported and for categorical variables, the frequencies and percentages will be reported. Between-group comparisons of change from baseline to 1-year follow-up in the primary and secondary continuous outcomes will be analysed using a generalized linear mixed model (GLMM). Testing for normality of distributions of outcomes will be based both on the Shapiro-Wilks test and a visual analysis of the histogram plot. Categorical secondary outcomes will be analysed using the ordinal logistic regression function under GLMM. A two-sided p-value less than 0.05 will be considered as statistical significance. An analysis will be done on the nature of the missing data to determine if the data was missing at random or a systemic bias was present resulting the missing data.

Data management

All data will be monitored by the PI or the study team, independent on the study sponsor. Data quality measures include queries to identify outliers and missing data. A unique identifier will be assigned to each subject after enrolment to ensure patient confidentiality. Data will be collected and stored on the Research Electronic Data Capture (REDCAP) system which is a widely used and secure web application for clinical data management in research. The REDCAP system is password protected and will only be accessible by the study team.

COMPONENT 2: economic evaluation

Aim and study design

The aim of the economic evaluation is to evaluate the cost-effectiveness of a personalized, community based 12-week multidisciplinary program for patients with knee OA. The Panel on Cost-Effectiveness in Health and Medicine recommends the use of a societal perspective to ensure that potentially important indirect costs such as productivity and caregiver cost would not be omitted [68]. The study will be conducted from a societal perspective to determine the cost-effectiveness of the intervention [68]. Results from the economic evaluation will be reported based on the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement [69].

Cost estimation and outcome measurement

Cost data will be collected via hospital administrative databases and patient-reported questionnaires to estimate direct medical, direct non-medical and indirect costs. Indirect costs include health-related productivity loss due to knee OA [70] from absenteeism and presenteeism, measured with the Work Productivity and Activity Impairment Questionnaire (WPAI) [71]. The scope of the cost data collection was based on the validated OA Cost and Consequences Questionnaire (OCC-Q) [72] and adapted to the Singapore context to ensure that all relevant sources of cost were collected. The cost questionnaire used can be found in Additional file 3. Cost data will be collected at 3 monthly intervals till 1-year follow-up.

The primary measure of health benefit will be Quality of Life Years (QALYs) measured using the EQ-5D [51]. The incremental cost-effectiveness ratio (ICER) over the trial period of this multidisciplinary non-surgical community-based program for knee OA compared to usual care will be determined.

COMPONENT 3: implementation and evaluation framework

RE-AIM framework

The RE-AIM framework has been proposed as an appropriate model to strengthen the case for policy change and implementation for knee OA [11]. A recent study in Canada in 2018 used the RE-AIM model to evaluate the cross-cultural adaption and implementation of the GLA:D program [30] for hip and knee OA [73]. Table 4 outlines the definition and proposed data collection based on the RE-AIM criteria.

Table 4 RE-AIM framework and Data Collection

A process evaluation will be embedded in the study. The process evaluation is key in understanding the why and the how of any intervention by examining its implementation, mechanisms of impact and contextual factors. The MRC has developed a set of guidelines for the conduct of process evaluations [74]. MRC recommends a basic framework for process evaluation with a different emphasis at each stage of the study. In the pilot phase, the key would be understanding the feasibility and intervention design optimization. In the main trial phase, the focus is on the fidelity of actual delivery, context and mechanism of impact. Context includes anything external to the intervention that may act as a barrier or facilitator to its implementation. The mechanism of impact seeks to identify the potential causal pathways that resulted in the changes seen.

In addition, the Global Alliance for Musculoskeletal Health (GMUSC) have proposed a framework to help individuals and organization with the planning, implementation and evaluation of models of care (MoC) in MSK health [75]. The implementation and evaluation framework in this study will utilize all 3 frameworks by using RE-AIM framework to guide the focus areas, the MRC process evaluation to understand the underlying mechanisms and the GMUSC framework to ensure system-level relevance for scalability. Results from the study will be reported according to the Standards for Reporting Implementation Studies (StaRI) [76].

Qualitative study methodology

A combination of deductive and iterative approaches will be used. A literature review will be conducted to generate themes for the study topic guide. A combination of questionnaires and semi-structured interviews will be conducted based on the topic guide. Purposeful sampling with both healthcare professionals and patients involved in the study will be used to identify appropriate participants for interviews.

Interviews will be conducted by an independent assessor with previous experience in qualitative research not directly involved in the care of the patients. Any interviewer pre-existing bias will be identified and recorded. Transcripts and audio recordings will be stored digitally and analysed using a qualitative analysis program to code data, link concepts, examine similarities and differences and review patterns and themes. Coding will be done iteratively.

Themes emanating from transcripts will be identified through a framework method approach done by 2 independent researchers supervised by a senior researcher with significant experience in qualitative research to ensure inter-observer reliability. Using the framework method, the data is reduced through a matrix comparing categories of data [77]. The framework method has been shown to be an appropriate method for the evaluation of multidisciplinary complex intervention. Data will be sampled till saturation. Results will be reported according to the Consolidated criteria for reporting qualitative research (COREQ) guideline [78].

Discussion and conclusion

A rapidly aging global population has resulted in an OA epidemic that is currently being poorly managed on a global scale. CONNACT is a community-based, multidisciplinary 12-week program that uniquely uses an individualized approach based on a triaging criterion to tailor the treatment to each patient coupled with a strong emphasis on patient activation and self-management. Traditional MoC for knee OA utilize a step-wise approach where all patients get baseline education, exercise and weight loss advice before gradually moving up the treatment ladder if treatment is unsuccessful [79]. In line with the “right care, delivered at the right time, by the right team, in the right place, with the right resources” philosophy, CONNACT proposes the use of an individualized approach through the use of a triaging criterion.

A complex intervention is defined by the MRC as an intervention that contains several interacting components [12]. There are several dimensions of complexity that can exist including the interaction between components of the control and intervention arms, difficulty of behaviours change required to deliver or receive the intervention, number of groups targeted, variability of outcomes to the degree of flexibility of intervention permitted. With rapidly evolving healthcare systems, complex interventions are being developed in the common drive to provide cost effective, sustainable care for patients. However due its inherent nature, there are issues in describing, developing, documenting and implementing complex intervention [80].

CONNACT MoC is a complex intervention that aims to promote long term sustainable behavioural change for patients with knee OA. In line with the MRC guidance for developing and evaluating complex interventions, building from a pilot feasibility study, this study protocol describes a comprehensive approach including an RCT, economic evaluation and process evaluation using a mixed method approach. The primary aim of this study is to determine the clinical effectiveness of the CONNACT MoC compared to usual care. The secondary aims are: a) To determine the cost-effectiveness and b) To develop an evaluation and implementation framework to inform large scale implementation for this MoC. The study will utilize an explanatory sequential mixed methods design where the qualitative data will be critical in providing context for the quantitative results allowing for a clearer interpretation.

Results from this study will help clinicians and healthcare administrators work side by side to avoid the “valley of death”, bridge the gap between research and clinical practice, guiding the sustainable and effective large-scale implementation of the CONNACT MoC for knee OA. In addition, CONNACT can serve as a basis for similar multidisciplinary complex MoC for chronic degenerative musculoskeletal conditions to be developed in line with the MRC guidelines.

Availability of data and materials

Not applicable.



Collaborative Model of Care between Orthopaedics and Allied Health Professionals Trial






Model of Care


Randomized Controlled Trial


National Institute of Health and Care Excellence


American College of Sports Medicine


Neuromuscular Exercise


OA Research Society International


Knee Injury and OA Outcome Score


EuroQol 5 dimensions 5 level


Body Mass Index


Patient Health Questionnaire 4


Pain, Enjoyment, General Activity Scale


Acceptance and Commitment Therapy


Food Frequency Questionnaire




Patient Activation Measure


Global Perceived Effect


Patient Acceptable Symptom State


Sports Injury Rehabilitation Adherence Scale


Principal Investigator


Standard Deviation


Generalized Linear Mixed Model


  1. 1.

    Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73(7):1323–30.

    PubMed  Article  Google Scholar 

  2. 2.

    McGrory B, Weber K, Lynott JA, Richmond JC, Davis CM 3rd, Yates A Jr, et al. The American Academy of Orthopaedic surgeons evidence-based clinical practice guideline on surgical Management of Osteoarthritis of the knee. J Bone Joint Surg Am. 2016;98(8):688–92.

    PubMed  Article  Google Scholar 

  3. 3.

    McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthr Cartil. 2014;22(3):363–88.

    CAS  Article  Google Scholar 

  4. 4.

    Australian Institute for Health and Welfare (2010). Use of health services for arthritis and osteoporosis, in Arthritis Series no. 14. Cat. no. PHE 130. AIHW:Canberra.

  5. 5.

    Basedow M, Esterman A. Assessing appropriateness of osteoarthritis care using quality indicators: a systematic review. J Eval Clin Pract. 2015;21(5):782–9.

    PubMed  Article  Google Scholar 

  6. 6.

    Hagen KB, Smedslund G, Osteras N, Jamtvedt G. Quality of community-based osteoarthritis care: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2016;68(10):1443–52.

    Article  Google Scholar 

  7. 7.

    Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89(4):780–5.

    PubMed  Article  Google Scholar 

  8. 8.

    Coggon D, Reading I, Croft P, McLaren M, Barrett D, Cooper C. Knee osteoarthritis and obesity. Int J Obes Relat Metab Dis. 2001;25(5):622–7.

    CAS  Article  Google Scholar 

  9. 9.

    Mulcahy H, Chew FS. Current concepts in knee replacement: complications. AJR Am J Roentgenol. 2014;202(1):W76–86.

    PubMed  Article  Google Scholar 

  10. 10.

    Grover A, Joshi A. An overview of chronic disease models: a systematic literature review. Global J Health Sci. 2014;7(2):210–27.

    Article  Google Scholar 

  11. 11.

    Allen KD, Choong PF, Davis AM, Dowsey MM, Dziedzic KS, Emery C, et al. Osteoarthritis: models for appropriate care across the disease continuum. Best Pract Res Clin Rheumatol. 2016;30(3):503–35.

    PubMed  Article  Google Scholar 

  12. 12.

    Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ (Clin Res ed). 2008;337:a1655.

    Google Scholar 

  13. 13.

    Tan BY, Ding BTK, Pereira MJ, Skou ST, Thumboo J, Car J. Collaborative Model of Care between Orthopaedics and Allied Healthcare Professionals Trial (CONNACT) – A Feasibility Study in patients with knee osteoarthritis using a mixed method approach. PREPRINT (Version 1) available at Research Square. 2020.

  14. 14.

    Peters D, Tran N, Adam T, Alliance for Health Policy and Systems Research, World Health Organization. Implementation research in health: a practical guide. 2013.

  15. 15.

    Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50(3):217–26.

    PubMed  PubMed Central  Article  Google Scholar 

  16. 16.

    Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med. 2011;104(12):510–20.

    PubMed  PubMed Central  Article  Google Scholar 

  17. 17.

    Klesges LM, Estabrooks PA, Dzewaltowski DA, Bull SS, Glasgow RE. Beginning with the application in mind: designing and planning health behavior change interventions to enhance dissemination. Ann Behav Med. 2005;29(2):66–75.

    PubMed  Article  Google Scholar 

  18. 18.

    Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M. The PRECIS-2 tool: designing trials that are fit for purpose. BMJ (Clin Res ed). 2015;350:h2147.

    Google Scholar 

  19. 19.

    Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200–7.

    PubMed  PubMed Central  Article  Google Scholar 

  20. 20.

    McAlindon TE, Driban JB, Henrotin Y, Hunter DJ, Jiang GL, Skou ST, et al. OARSI clinical trials recommendations: design, conduct, and reporting of clinical trials for knee osteoarthritis. Osteoarthr Cartil. 2015;23(5):747–60.

    CAS  Article  Google Scholar 

  21. 21.

    Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ (Clin Res ed). 2010;340:c869.

    Article  Google Scholar 

  22. 22.

    National Institute for Health and Care Excellence (NICE) Guideline 2014. Osteoarthritis: care and management.

  23. 23.

    Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16(4):494–502.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  24. 24.

    Roos EM, Lohmander LS. The knee injury and osteoarthritis outcome score (KOOS): from joint injury to osteoarthritis. Health Qual Life Outcomes. 2003;1:64.

    PubMed  PubMed Central  Article  Google Scholar 

  25. 25.

    Tan BY, Ding BTK, Pereira MJ, Skou ST, Thumboo J, Car J. Collaborative model of care between Orthopaedics and allied healthcare professionals trial (CONNACT) - a feasibility study in patients with knee osteoarthritis using a mixed method approach. BMC Musculoskelet Disord. 2020;21(1):592.

    PubMed  PubMed Central  Article  Google Scholar 

  26. 26.

    Sanders JO, Murray J, Gross L. Non-arthroplasty treatment of osteoarthritis of the knee. J Am Acad Orthop Surg. 2014;22(4):256–60.

    PubMed  Article  Google Scholar 

  27. 27.

    Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687.

    PubMed  Article  Google Scholar 

  28. 28.

    Slade S, Dionne C, Underwood M, Buchbinder R, Beck B, Bennell K, et al. Consensus on exercise reporting template (CERT): modified Delphi study. Phys Ther. 2016;96.

  29. 29.

    American College of Sport Medicine (ACSM) Guidelines for Exercise Testing and Prescription.

  30. 30.

    Skou ST, Roos EM. Good life with osteoArthritis in Denmark (GLA:D): evidence-based education and supervised neuromuscular exercise delivered by certified physiotherapists nationwide. BMC Musculoskelet Disord. 2017;18(1):72.

    PubMed  PubMed Central  Article  Google Scholar 

  31. 31.

    National Institute for Health and Care Excellence (NICE) Guideline 2014. Weight management: lifestyle services for overweight or obese adults. .

  32. 32.

    Hayes SC SK, Wilson KG. Acceptance and commitment therapy (an experiential approach to behavior change): New York: a division of Guildford publications Inc; 1999.

  33. 33.

    Yang S-Y, McCracken L. Acceptance and commitment therapy for chronic pain. J Clin Outcomes Manag. 2014;21:134–44.

    Google Scholar 

  34. 34.

    Ngooi B. What are the crucial components of patient activation interventions? Biomedical Journal of Scientific & Technical Research. 2017;1.

  35. 35.

    Kroenke K, Spitzer RL, Williams JB, Lowe B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. 2009;50(6):613–21.

    PubMed  Google Scholar 

  36. 36.

    Krebs EE, Lorenz KA, Bair MJ, Damush TM, Wu J, Sutherland JM, et al. Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference. J Gen Intern Med. 2009;24(6):733–8.

    PubMed  PubMed Central  Article  Google Scholar 

  37. 37.

    Hibbard JH, Mahoney ER, Stockard J, Tusler M. Development and testing of a short form of the patient activation measure. Health Serv Res. 2005;40(6 Pt 1):1918–30.

    PubMed  PubMed Central  Article  Google Scholar 

  38. 38.

    Sharma A, Kudesia P, Shi Q, Gandhi R. Anxiety and depression in patients with osteoarthritis: impact and management challenges. Open Access Rheumatol. 2016;8:103–13.

    PubMed  PubMed Central  Article  Google Scholar 

  39. 39.

    Sharma L, Cahue S, Song J, Hayes K, Pai Y-C, Dunlop D. Physical functioning over three years in knee osteoarthritis: role of psychosocial, local mechanical, and neuromuscular factors. Arthritis Rheum. 2003;48(12):3359–70.

    PubMed  Article  PubMed Central  Google Scholar 

  40. 40.

    Cleeland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med Singap. 1994;23(2):129–38.

    CAS  PubMed  Google Scholar 

  41. 41.

    Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008;9(2):105–21.

    Article  Google Scholar 

  42. 42.

    Wise BL, Niu J, Zhang Y, Wang N, Jordan JM, Choy E, et al. Psychological factors and their relation to osteoarthritis pain. Osteoarthr Cartil. 2010;18(7):883–7.

    CAS  PubMed Central  Article  PubMed  Google Scholar 

  43. 43.

    Hibbard JH, Greene J. What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs. Health affairs (Project Hope). 2013;32(2):207–14.

    Article  Google Scholar 

  44. 44.

    Hibbard JH, Greene J, Tusler M. Improving the outcomes of disease management by tailoring care to the patient's level of activation. Am J Manag Care. 2009;15(6):353–60.

    PubMed  Google Scholar 

  45. 45.

    Hsu WC, Araneta MRG, Kanaya AM, Chiang JL, Fujimoto W. BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening. Diabetes Care. 2015;38(1):150.

    PubMed  Article  Google Scholar 

  46. 46.

    Yang S-Y, McCracken LM, Moss-Morris R. Psychological treatment needs for chronic pain in Singapore and the relevance of the psychological flexibility model. Pain Med. 2016;18(9):1679–94.

    Google Scholar 

  47. 47.

    Lally P, van Jaarsveld CHM, Potts HWW, Wardle J. How are habits formed: Modelling habit formation in the real world. Eur J Soc Psychol. 2010;40(6):998–1009.

    Article  Google Scholar 

  48. 48.

    McCarthy CJ. The effectiveness of supplementing a home exercise programme with a class based exercise programme in the treatment of knee osteoarthritis. Effectiveness of Supplementing a Home Exercise Programme With a Class Based Exercise Programme in the Treatment of Knee Osteoarthritis. 2001:1-.

  49. 49.

    Burke S, Carron A, Eys M, Ntoumanis N, Estabrooks P. Group versus individual approach? A meta-analysis of the effectiveness of interventions to promote physical activity. Sport Exer Psychol Rev. 2005;2.

  50. 50.

    Messier SP, Callahan LF, Golightly YM, Keefe FJ. OARSI clinical trials recommendations: design and conduct of clinical trials of lifestyle diet and exercise interventions for osteoarthritis. Osteoarthr Cartil. 2015;23(5):787–97.

    CAS  Article  Google Scholar 

  51. 51.

    EuroQol--a new facility for the measurement of health-related quality of life. Health policy (Amsterdam, Netherlands). 1990;16(3):199–208.

  52. 52.

    Neelakantan N, Whitton C, Seah S, Koh H, Rebello SA, Lim JY, et al. Development of a Semi-Quantitative Food Frequency Questionnaire to Assess the Dietary Intake of a Multi-Ethnic Urban Asian Population. Nutrients. 2016;8(9).

  53. 53.

    Scott W, McCracken LM. Patients' impression of change following treatment for chronic pain: global, specific, a single dimension, or many? J Pain. 2015;16(6):518–26.

    PubMed  Article  Google Scholar 

  54. 54.

    Dougados M, Moore A, Yu S, Gitton X. Evaluation of the patient acceptable symptom state in a pooled analysis of two multicentre, randomised, double-blind, placebo-controlled studies evaluating lumiracoxib and celecoxib in patients with osteoarthritis. Arthritis Res Ther. 2007;9:R11.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  55. 55.

    Kolt GS, Brewer BW, Pizzari T, Schoo AMM, Garrett N. The sport injury rehabilitation adherence scale: a reliable scale for use in clinical physiotherapy. Physiotherapy. 2007;93(1):17–22.

    Article  Google Scholar 

  56. 56.

    Naal FD, Impellizzeri FM, Leunig M. Which is the best activity rating scale for patients undergoing total joint arthroplasty? Clin Orthop Relat Res. 2009;467(4):958–65.

    PubMed  Article  Google Scholar 

  57. 57.

    Schoenthaler M, Miernik A, Offner K, Karcz WK, Hauschke D, Sevcenco S, et al. The cumulative analgesic consumption score (CACS): evaluation of a new score to describe postsurgical analgesic consumption as a surrogate parameter for postoperative pain and invasiveness of surgical procedures. Int Braz J Urol. 2014;40(3):330–6.

    PubMed  Article  Google Scholar 

  58. 58.

    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  59. 59.

    Mahoney FI, Barthel DW. FUNCTIONAL EVALUATION: The BARTHEL index. Maryland State Med J. 1965;14:61–5.

    CAS  Google Scholar 

  60. 60.

    Parker MJ, Palmer CR. A new mobility score for predicting mortality after hip fracture. J Bone Joint Surg Br Volume. 1993;75(5):797–8.

    CAS  Article  Google Scholar 

  61. 61.

    Skou ST, Rasmussen S, Laursen MB, Rathleff MS, Arendt-Nielsen L, Simonsen O, et al. The efficacy of 12 weeks non-surgical treatment for patients not eligible for total knee replacement: a randomized controlled trial with 1-year follow-up. Osteoarthr Cartil. 2015;23(9):1465–75.

    CAS  Article  Google Scholar 

  62. 62.

    Xie F, Li SC, Roos EM, Fong KY, Lo NN, Yeo SJ, et al. Cross-cultural adaptation and validation of Singapore English and Chinese versions of the knee injury and osteoarthritis outcome score (KOOS) in Asians with knee osteoarthritis in Singapore. Osteoarthr Cartil. 2006;14(11):1098–103.

    CAS  Article  Google Scholar 

  63. 63.

    Dobson F, Hinman RS, Roos EM, Abbott JH, Stratford P, Davis AM, et al. OARSI recommended performance-based tests to assess physical function in people diagnosed with hip or knee osteoarthritis. Osteoarthr Cartil. 2013;21(8):1042–52.

    CAS  Article  Google Scholar 

  64. 64.

    Terwee CB, Bouwmeester W, van Elsland SL, de Vet HC, Dekker J. Instruments to assess physical activity in patients with osteoarthritis of the hip or knee: a systematic review of measurement properties. Osteoarthr Cartil. 2011;19(6):620–33.

    CAS  Article  Google Scholar 

  65. 65.

    Luo N, Wang P, Thumboo J, Lim YW, Vrijhoef HJ. Valuation of EQ-5D-3L health states in Singapore: modeling of time trade-off values for 80 empirically observed health states. PharmacoEconomics. 2014;32(5):495–507.

    PubMed  Article  Google Scholar 

  66. 66.

    Roddy E, Zhang W, Doherty M, Arden NK, Barlow J, Birrell F, et al. Evidence-based recommendations for the role of exercise in the management of osteoarthritis of the hip or knee--the MOVE consensus. Rheumatology (Oxford, England). 2005;44(1):67–73.

    CAS  Article  Google Scholar 

  67. 67.

    McLean S, Holden MA, Potia T, Gee M, Mallett R, Bhanbhro S, et al. Quality and acceptability of measures of exercise adherence in musculoskeletal settings: a systematic review. Rheumatology (Oxford, England). 2017;56(3):426–38.

    Google Scholar 

  68. 68.

    Sanders GD, Neumann PJ, Basu A, Brock DW, Feeny D, Krahn M, et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. Jama. 2016;316(10):1093–103.

    PubMed  Article  PubMed Central  Google Scholar 

  69. 69.

    Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. BMJ (Clin Res ed). 2013;346:f1049.

    Google Scholar 

  70. 70.

    Rice DP. Estimating the cost of illness. Am J Public Health Nation’s Health. 1967;57(3):424–40.

    CAS  Article  Google Scholar 

  71. 71.

    Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics. 1993;4(5):353–65.

    CAS  PubMed  Article  Google Scholar 

  72. 72.

    Pinto D, Robertson MC, Hansen P, Abbott JH. Good agreement between questionnaire and administrative databases for health care use and costs in patients with osteoarthritis. BMC Med Res Methodol. 2011;11:45.

    PubMed  PubMed Central  Article  Google Scholar 

  73. 73.

    Davis AM, Kennedy D, Wong R, Robarts S, Skou ST, McGlasson R, et al. Cross-cultural adaptation and implementation of good life with osteoarthritis in Denmark (GLA:D): group education and exercise for hip and knee osteoarthritis is feasible in Canada. Osteoarthr Cartil. 2018;26(2):211–9.

    CAS  Article  Google Scholar 

  74. 74.

    Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, et al. Process evaluation of complex interventions: Medical Research Council guidance. BMJ (Clin Res ed). 2015;350:h1258.

    Google Scholar 

  75. 75.

    Briggs AM, Jordan JE, Jennings M, Speerin R, Bragge P, Chua J, et al. Supporting the evaluation and implementation of musculoskeletal models of care: a globally informed framework for judging readiness and success. Arthritis Care Res (Hoboken). 2017;69(4):567–77.

    PubMed  Article  Google Scholar 

  76. 76.

    Pinnock H, Barwick M, Carpenter CR, Eldridge S, Grandes G, Griffiths CJ, et al. Standards for Reporting Implementation Studies (StaRI) Statement. BMJ (Clin Res Ed). 2017;356:i6795.

    Article  Google Scholar 

  77. 77.

    Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13:117.

    PubMed  PubMed Central  Article  Google Scholar 

  78. 78.

    Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57.

    PubMed  Article  Google Scholar 

  79. 79.

    Roos EM, Juhl CB, Roos EM, Juhl CB. Osteoarthritis 2012 year in review: rehabilitation and outcomes. Osteoarthritis Cartilage. 2012;20(12):1477–83.

    CAS  PubMed  Article  Google Scholar 

  80. 80.

    Campbell NC, Murray E, Darbyshire J, Emery J, Farmer A, Griffiths F, et al. Designing and evaluating complex interventions to improve health care. BMJ (Clin Res Ed). 2007;334(7591):455–9.

    Article  Google Scholar 

Download references




Ng Teng Fong Health Innovation Program Grant $200,000. The funding body was not involved in the study design.

Author information




BYT was the lead investigator. All the authors (BYT, MJP, YSY, DJH, STS, JT, JC) were involved in the study methodology design and the preparation of the manuscript and have approved the final manuscript.

Corresponding author

Correspondence to Bryan Yijia Tan.

Ethics declarations

Ethics approval and consent to participate

Ethics approval was obtained through the Institution Review Board prior to the conduct of the study (National Healthcare Group Domain Specific Review Board Ref: 2018/00408). Written consent will be obtained from the study participants.

Consent for publication


Competing interests

The authors declare that they have no competing interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Additional file 1.

Appendix 1 – Intervention Description. (DOCX 26 kb)

Additional file 2.

Appendi× 2 – Patient Reported Exercise Compliance Questionnaire. (PDF 265 kb)

Additional file 3.

Appendi× 3 – Cost Questionnaire. (DOCX 43 kb)

Additional file 4.

Appendix 4 – SPIRIT diagram. (DOC 74 kb)

Additional file 5.

Appendix 5 – SPIRIT checklist. (DOC 124 kb)

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tan, B.Y., Pereira, M.J., Yang, S. et al. Collaborative model of care between Orthopaedics and allied healthcare professionals in knee osteoarthritis (CONNACT): study protocol for an effectiveness-implementation hybrid randomized control trial. BMC Musculoskelet Disord 21, 684 (2020).

Download citation


  • Study protocol
  • Effectiveness-implementation hybrid
  • Mixed methods
  • Knee osteoarthritis
  • Model of care
  • Randomized control trial